Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14301 - 14325 of 14515 in total
Ly2300559 has been used in trials studying the prevention of Migraine Headache.
Investigational
Experimental
Experimental
Experimental
Experimental
Dextromethadone is under investigation in clinical trial NCT00588640 (Study of D-Methadone in Patients With Chronic Pain).
Investigational
NLX-P101, gene therapy is developed by Neurologix to treat Parkinson’s disease. The gene is glutamic acid decarboxylase (GAD), whose product synthesizes the major inhibitory neurotransmitter in the brain, (gamma)-aminobutyric acid (GABA), and targets the subthalamic nucleus (STN), which is overactive in patients with Parkinson’s disease. NLX-P101 is being evaluated as...
Investigational
Matched Description: … product synthesizes the major inhibitory neurotransmitter in the brain, (gamma)-aminobutyric acid (GABA), and
PF-00446687 has been investigated for the treatment of Erectile Dysfunction.
Investigational
Experimental
Illicit
Experimental
Experimental
Displaying drugs 14301 - 14325 of 14515 in total